AbbVie Inc. (ABBV)

AbbVie Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	18,067	12,814	9,201	9,746	8,449	39,924
Short-Term Investments	2	2	28	84	30	0
Cash & Cash Equivalents	18,069	12,816	9,229	9,830	8,479	39,924
Cash Growth	168.80%	38.87%	-6.11%	15.93%	-78.76%	395.27%
Receivables	11,949	11,155	11,254	9,977	8,822	5,428
Inventory	4,245	4,099	3,579	3,128	3,310	1,813
Other Current Assets	4,608	4,932	4,401	4,993	3,562	2,354
Total Current Assets	38,871	33,002	28,463	27,928	24,173	49,519
Property, Plant & Equipment	4,980	4,989	4,935	5,110	5,248	2,962
Long-Term Investments	305	304	241	277	293	93
Goodwill and Intangibles	95,651	87,903	99,595	108,330	116,000	34,253
Other Long-Term Assets	9,067	8,513	5,571	4,884	4,851	2,288
Total Long-Term Assets	110,003	101,709	110,342	118,601	126,392	39,596
Total Assets	148,874	134,711	138,805	146,529	150,565	89,115
Accounts Payable	31,326	30,650	25,402	22,699	20,159	11,832
Current Debt	10,196	7,191	4,136	12,495	8,502	3,753
Total Current Liabilities	41,522	37,841	29,538	35,194	28,661	15,585
Long-Term Debt	63,805	52,194	59,135	64,189	77,554	62,975
Other Long-Term Liabilities	35,500	34,279	32,845	31,710	31,253	18,727
Total Long-Term Liabilities	99,305	86,473	91,980	95,899	108,807	81,702
Total Liabilities	140,827	124,314	121,518	131,093	137,468	97,287
Total Debt	74,001	59,385	63,271	76,684	86,056	66,728
Debt Growth	19.18%	-6.14%	-17.49%	-10.89%	28.97%	65.54%
Retained Earnings	-2,384	-1,000	4,784	3,127	1,055	4,717
Comprehensive Income	-2,454	-2,305	-2,199	-2,899	-3,117	-3,596
Shareholders' Equity	8,007	10,360	17,254	15,408	13,076	-8,172
Net Cash / Debt	-55,932	-46,569	-54,042	-66,854	-77,577	-26,804
Net Cash Per Share	-31.55	-26.27	-30.39	-37.62	-46.37	-18.06
Working Capital	-2,651	-4,839	-1,075	-7,266	-4,488	33,934
Book Value Per Share	4.53	5.86	9.74	8.71	7.84	-5.52

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).